Biotechnology
Biopharmaceutical
Pharmaceutical

Fate Therapeutics

1,814

$24.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.27 (+5.54%) As of 2:57 PM EDT today
+$1.27 (+5.54%) Today

Why Robinhood?

You can buy or sell FATE and other stocks, options, ETFs, and crypto commission-free!

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products include immuno-ocology candidates and immuno-regulation candidates. Read More The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

CEO
J. Scott Wolchko
Employees
178
Headquarters
San Diego, California
Founded
2007
Market Cap
1.84B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.53M
High Today
$25.46
Low Today
$23.73
Open Price
$24.41
Volume
998.29K
52 Week High
$32.39
52 Week Low
$12.59

Collections

Biotechnology
Biopharmaceutical
Pharmaceutical
Health
Cancer Prevention
Therapy
Technology
2013 IPO

FATE Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, After Hours

People Also Bought

Viking Therapeutics

52,040

$4.54

+3.18%

Viking Therapeutics

52,040

$4.54

+3.18%

Editas Medicine

10,339

$20.83

+6.49%

Amarin

35,885

$4.80

+0.42%

Iovance Biotherapeutics

3,661

$28.10

-3.30%

You May Also Like

MTC
MOSY
CENX
WLDN
MRTX
ROM
DLPNW
VBF
WSBC
OCFC
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy FATE

Market Price$24.21
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell FATE stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up